4.8 Review

Emerging Functions of Amphiregulin in Orchestrating Immunity, Inflammation, and Tissue Repair

期刊

IMMUNITY
卷 42, 期 2, 页码 216-226

出版社

CELL PRESS
DOI: 10.1016/j.immuni.2015.01.020

关键词

-

资金

  1. European Union
  2. Medical Research Council [MR/M011755/1]
  3. Asthma UK
  4. National Institutes of Health [AI107588, AI031678, AI061570, AI095608, AI074878, AI095466, AI106697, AI102942, AI097333]
  5. Crohns and Colitis Foundation of America
  6. Burroughs Wellcome Fund
  7. MRC [MR/M011755/1] Funding Source: UKRI
  8. Medical Research Council [MR/M011755/1] Funding Source: researchfish

向作者/读者索取更多资源

Type 2 inflammatory responses can be elicited by diverse stimuli, including toxins, venoms, allergens, and infectious agents, and play critical roles in resistance and tolerance associated with infection, wound healing, tissue repair, and tumor development. Emerging data suggest that in addition to characteristic type 2-associated cytokines, the epidermal growth factor (EGF)-like molecule Amphiregulin (AREG) might be a critical component of type 2-mediated resistance and tolerance. Notably, numerous studies demonstrate that in addition to the established role of epithelial- and mesenchymal-derived AREG, multiple leukocyte populations including mast cells, basophils, group 2 innate lymphoid cells (ILC2s), and a subset of tissue-resident regulatory CD4(+) T cells can express AREG. In this review, we discuss recent advances in our understanding of the AREG-EGF receptor pathway and its involvement in infection and inflammation and propose a model for the function of this pathway in the context of resistance and tissue tolerance.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据